共 50 条
- [42] What is the Right Margin for Target Delineation in Stereotactic Body Radiation Therapy (SBRT) for Previously-Irradiated, Recurrent Squamous Cell Carcinoma of the Head and Neck? AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 185 - 185
- [43] Comparison of Clinical Outcomes of Different Radiation Strategies in Postoperative Radiation Therapy for Patients with Head and Neck Squamous Cell Carcinoma: A Propensity-Score Matched Analysis INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E356 - E357
- [45] Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 116 (01): : 55 - 60
- [47] Evaluation of the EGFR-Inhibitor Zalutumumab Given With Primary Curative (Chemo)radiation Therapy to Patients With Squamous Cell Carcinoma of the Head and Neck: Results of the DAHANCA 19 Randomized Phase 3 Trial Definitive Management of Head-and-Neck Squamous Cell Carcinoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 465 - 465
- [48] Five-year Outcomes of Oropharynx (OPX) Targeted Radiation Therapy (RT) for Metastatic Squamous Cell Carcinoma of Unknown Primary (MUP) in the Head and Neck INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S22 - S22